Interleukin-32 as a novel NAFLD biomarker in PNPLA3 I148M variant carriers

被引：0

作者：

Baselli, Guido Alessandro ^{[1
,2
]}

Dongiovanni, Paola ^{[3
]}

Rametta, Raffaela ^{[3
]}

Meroni, Marica ^{[3
]}

Pelusi, Serena ^{[1
,2
]}

Maggioni, Marco ^{[4
]}

Badiali, Sara ^{[5
]}

Pingitore, Piero ^{[6
]}

Montalcini, Tiziana ^{[7
]}

Rossi, Giorgio ^{[1
,8
]}

Prati, Daniele ^{[2
]}

Fargion, Silvia ^{[1
,3
]}

Mancina, Rosellina ^{[6
]}

Romeo, Stefano ^{[6
,7
]}

Valenti, Luca ^{[1
,2
]}

机构：

[1] Univ Milan, Pathophysiol & Transplantat, Milan, Italy

[2] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Transfus Ctr, Translat Med, Milan, Italy

[3] Fdn IRCCS Ca Granda, Gen Med & Metab Dis, Milan, Italy

[4] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Pathol, Milan, Italy

[5] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Surg, Milan, Italy

[6] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Catanzaro, Italy

[7] Univ Gothenburg, Sahlgrenska Ctr Cardiovasc & Metab Res, Cardiol Dept, Gothenburg, Sweden

[8] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Liver Transplantat Ctr, Milan, Italy

来源：

JOURNAL OF HEPATOLOGY | 2019年 / 70卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

SAT-275

引用

页码：E755 / E755

页数：1

共 50 条

[31] ASSOCIATION BETWEEN PNPLA3 I148M POLYMORPHISM AND NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) IN THE INDIAN CONTINENT
Rangegowda, D.
Sharma, S.
Kumar, K. N. Chandan
Maiwal, R.
Vashista, C.
Sharma, M. K.
Bhatia, V.
Bhadoria, A. S.
Rastogi, A.
Sarin, S.
JOURNAL OF HEPATOLOGY, 2015, 62 : S748 - S748
[32] The rs738409 (I148M) Variant of the PNPLA3 Gene and Type 2 Diabetes in Yakutia
Sydykova, Lubov A.
Kurtanov, Khariton A.
Borisova, Natalia V.
Pavlova, Nadejda I.
Stepanov, Konstantin M.
Markova, Sardana V.
Makarov, Albert D.
Alekseeva, Sardana N.
Antipina, Uliana D.
INTERNATIONAL JOURNAL OF BIOMEDICINE, 2018, 8 (03) : 201 - 205
[33] The PNPLA3 I148M variant and chronic liver disease: When a genetic mutation meets nutrients
Maglio, Cristina
Pirazzi, Carlo
Pujia, Arturo
Valenti, Luca
Romeo, Stefano
FOOD RESEARCH INTERNATIONAL, 2014, 63 : 239 - 243
[34] PNPLA3 I148M Involved in Mechanism of Variability in Antilipogenesis Response to Exenatide
Chen, Yunzhi
Liang, Hua
Xu, Fen
DIABETES, 2020, 69
[35] PNPLA3 I148M and response to treatment for hepatic steatosis: A systematic review
Boeckmans, Joost
Gatzios, Alexandra
Schattenberg, Joern M.
Koek, Ger H.
Rodrigues, Robim M.
Vanhaecke, Tamara
LIVER INTERNATIONAL, 2023, 43 (05) : 975 - 988
[36] Mutant PNPLA3 I148M Protein as Pharmacological Target for Liver Disease
Valenti, Luca
Dongiovanni, Paola
HEPATOLOGY, 2017, 66 (04) : 1026 - 1028
[37] PNPLA3 I148M POLYMORPHISM, ETIOLOGY, AND CLINICAL FEATURES OF HEPATOCELLULAR CARCINOMA
Valenti, Luca
Motta, Benedetta M.
Bertelli, Cristina
Sangiovanni, Angelo
Rametta, Raffaela
Dongiovanni, Paola
Colombo, Massimo
Fargion, Silvia
Fracanzani, Anna Ludovica
HEPATOLOGY, 2011, 54 : 1292A - 1292A
[38] PNPLA3 I148M Interacts With Environmental Triggers to Cause Human Disease
Speliotes, Elizabeth K.
Schneider, Carolin Victoria
LIVER INTERNATIONAL, 2025, 45 (03)
[39] The I148M PNPLA3 variant is a novel key player modulating the proinflammatory and profibrogenic phenotype of human hepatic stellate cells
Bruschi, F. V.
Claudel, T.
Tardelli, M.
Caligiuri, A.
Stulnig, T. M.
Marra, F.
Trauner, M.
JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S45 - S45
[40] The PNPLA3 Variant Associated With Fatty Liver Disease (I148M) Accumulates on Lipid Droplets by Evading Ubiquitylation
BasuRay, Soumik
Smagris, Eriks
Cohen, Jonathan C.
Hobbs, Helen H.
HEPATOLOGY, 2017, 66 (04) : 1111 - 1124

← 1 2 3 4 5 →